Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety, Tolerability, and Pharmacodynamic Properties of IW-6463 in Healthy Elderly Subjects

NCT04240158 is registered in ClinicalTrials.gov with Tisento Therapeutics as lead sponsor.

NCT NCT04240158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety, Tolerability, and Pharmacodynamic Properties of IW-6463 in Healthy Elderly Subjects
Lead sponsor
Tisento Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
January 6, 2020
Completion date
May 22, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other